Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2007-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
DEFINED_POPULATION
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
10 diagnosed men in age 60 - 90 with Prostate Cancer
No interventions assigned to this group
2
10 patients with benign growth
No interventions assigned to this group
3
10 health volunteers
No interventions assigned to this group
4
10 patients diagnosed with other cancer
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Control Group 1: Males between the ages of 60-90 years, with diagnosed benign prostate hyperplasia -BPH.
Control Group 2: Males between the ages of 60-90 years, medically diagnosed as healthy.
Control Group 3: Males between the ages of 60-90 years, medically diagnosed with another form of cancer, not prostate.
Exclusion Criteria
Control Group 3:Other known systemic infection, nor urinary tract infection.
\-
60 Years
90 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziv Hospital
OTHER_GOV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nina Kucherski, MD
Role: PRINCIPAL_INVESTIGATOR
Ziv Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urology Department, Ziv Medical Center
Safed, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Nina Kucherski, MD
Role: CONTACT
Yihia Johari, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yihia Johari, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Klein O, Lin S, Embon O, Sazbon A, Zidan J, Kook AI. An approach for high sensitivity detection of prostate cancer by analysis of changes in structuredness of the cytoplasmic matrix of lymphocytes specifically induced by PSA-ACT. J Urol. 1999 Jun;161(6):1994-6.
Altman, Roberta. The prostate Answer Book. Warner Books, lnc., 1993.
American Cancer Society. National Cnference on Prostate Cancer. Philadelphia, Pennsylvania: September/October 1994.
Rous, Stephen N., M.D.; The prostate Book. W.W. Norton & Co., 1992.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP 7-251 S
Identifier Type: -
Identifier Source: org_study_id